Srini Akkaraju
Samsara Biocapital, Llc
Assets Managed
$1.029B
Holdings
22
Last Quarter
2026 - Q1
Filed Date
12d ago
Growth Rate
6.18%(2Q avg: 16.37%)
Sustained Growth
3 quarters
Portfolio positions
This chart displays the top 10 holdings in Samsara Biocapital, Llc's 2026 - Q1 portfolio, based on their 13F SEC filing, out of a total of 22 positions.
Assets under management
The assets under management (AUM) of Samsara Biocapital, Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 3 quarters. As of the latest 13F SEC filing for 2026 - Q1, they manage 1.029B in assets, with a quarterly growth rate of 6.18% and a 2-quarter average growth rate of 16.37%. The portfolio is managed by Srini Akkaraju, and others.
Portfolio holdings
| Investment | Portfolio % | Reported Value | Recent Activity |
|---|---|---|---|
SRRK Scholar Rock Holding Corp
| 32.95% | $339.089M 6.898M shares@ $49.16 avg price | |
MLYS Mineralys Therapeutics Inc
| 15.46% | $159.046M 5.871M shares@ $27.1 avg price | |
ALMS Alumis Inc
| 13.59% | $139.785M 6.345M shares@ $22.04 avg price | Increased 10.22% |
SEPN Septerna Inc
| 7.36% | $75.674M 3.149M shares@ $24.04 avg price | |
KLRS Kalaris Therapeutics Inc
| 7.26% | $74.71M 12.948M shares@ $5.77 avg price | |
SGP Spyglass Pharma Inc
| 5.32% | $54.669M 2.11M shares@ $25.91 avg price | New Position |
NGNE Neurogene Inc
| 3.37% | $34.617M 1.717M shares@ $20.16 avg price | |
IVA Inventiva Sa - Adr
| 2.81% | $28.831M 5.195M shares@ $5.56 avg price | |
STRO Sutro Biopharma Inc
| 2.58% | $26.476M 1.063M shares@ $24.92 avg price | Increased 419.74% |
JBIO Jade Biosciences Inc
| 1.33% | $13.612M 968,798 shares@ $14.06 avg price |
1-10 of 22